AlphaYouJH
Congress trade
Sen. John Hoeven (R-ND) bought $100K-$250K of AbbVie Inc. (NYSE) (ABBV) stock
John Hoeven, U.S. Senator (R-ND), disclosed a purchase of AbbVie Inc. (NYSE) (ABBV) stock worth $100K-$250K in a STOCK Act filing on Mar 9, 2015.
The trade happened on Feb 25, 2015, 12 days before it was made public.
ABBV has moved +333.7% since the trade date, from $60.62 to $262.90 (Oct 2, 2026 close).
- Traded
- Feb 25, 2015
- Disclosed
- Mar 9, 2015
- Filing delay
- 12 days
- Price since
- +333.7%
- Source
- STOCK Act disclosure
Other trades in this disclosure (1)
More ABBV insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.